(Q38869669)

English

HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study

scientific article published on 27 July 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 September 2017

HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study (English)

1 reference

Europe PubMed Central

7 September 2017

multicenter clinical trial

0 references

anti-retroviral agent

0 references

Sub-Saharan Africa

0 references

3

object named as

Cissy Kityo

1 reference

Europe PubMed Central

7 September 2017

Immaculate Nankya

11

object named as

Immaculate Nankya

1 reference

Europe PubMed Central

7 September 2017

Tobias F Rinke de Wit

16

object named as

Tobias F Rinke de Wit

1 reference

Europe PubMed Central

7 September 2017

1

object named as

Raph L Hamers

1 reference

Europe PubMed Central

7 September 2017

Wendy S Stevens

14

object named as

Wendy S Stevens

1 reference

Europe PubMed Central

7 September 2017

Carole L Wallis

2

object named as

Carole L Wallis

1 reference

Europe PubMed Central

7 September 2017

Kim C E Sigaloff

10

object named as

Kim C E Sigaloff

1 reference

Europe PubMed Central

7 September 2017

Margaret Siwale

4

object named as

Margaret Siwale

1 reference

Europe PubMed Central

7 September 2017

Francesca Conradie

6

object named as

Francesca Conradie

1 reference

Europe PubMed Central

7 September 2017

Mariette E Botes

7

object named as

Mariette E Botes

1 reference

Europe PubMed Central

7 September 2017

9

object named as

Akin Osibogun

1 reference

Europe PubMed Central

7 September 2017

Michèle van Vugt

15

object named as

Michèle van Vugt

1 reference

Europe PubMed Central

7 September 2017

Kishor Mandaliya

5

object named as

Kishor Mandaliya

1 reference

Europe PubMed Central

7 September 2017

8

object named as

Maureen Wellington

1 reference

Europe PubMed Central

7 September 2017

Ferdinand Wnm Wit

13

object named as

Ferdinand W Wit

1 reference

Europe PubMed Central

7 September 2017

PharmAccess African Studies to Evaluate Resistance (PASER)

17

object named as

PharmAccess African Studies to Evaluate Resistance (PASER)

1 reference

Europe PubMed Central

7 September 2017

author name string

Rob Schuurman

12

1 reference

Europe PubMed Central

7 September 2017

publication date

27 July 2011

1 reference

Europe PubMed Central

7 September 2017

Lancet Infectious Diseases

1 reference

Europe PubMed Central

7 September 2017

11

1 reference

Europe PubMed Central

7 September 2017

10

1 reference

Europe PubMed Central

7 September 2017

750-759

1 reference

Europe PubMed Central

7 September 2017

The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiretroviral-drug resistance among patients recently infected with HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Time trends in primary HIV-1 drug resistance among recently infected persons

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Transmission of drug-resistant HIV-1 is stabilizing in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.-2006.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Transmitted antiretroviral drug resistance among newly HIV-1 diagnosed young individuals in Kampala

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-1 drug resistance mutations are present in six percent of persons initiating antiretroviral therapy in Lusaka, Zambia.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

High prevalence of antiretroviral resistance in treated Ugandans infected with non-subtype B human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

TREAT Asia Quality Assessment Scheme (TAQAS) to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratories

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

An automated genotyping system for analysis of HIV-1 and other microbial sequences

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A statistical model for HIV-1 sequence classification using the subtype analyser (STAR).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Transmitted antiretroviral drug resistance surveillance among newly HIV type 1-diagnosed women attending an antenatal clinic in Entebbe, Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The Calculated Genetic Barrier for Antiretroviral Drug Resistance Substitutions Is Largely Similar for Different HIV-1 Subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1473-3099(11)70149-9

1 reference

Europe PubMed Central

7 September 2017

1 reference

Europe PubMed Central

7 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38869669&oldid=1858786137"